FDA Seeks Input on a Rare Deficiency and Chemotherapy
Published Date: 5/20/2025
Notice
Summary
The FDA is opening a public comment period to learn more about a condition called DPD deficiency, which can affect how people react to certain chemotherapy drugs like fluorouracil and capecitabine. This effort aims to gather info to keep patients safe and improve treatment. Anyone interested has until June 20, 2025, to share their thoughts—no costs or immediate changes yet, just gathering input!
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-23351, Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition
The FDA wants to officially say that N-acetyl-L-cysteine (NAC) can be sold as a dietary supplement. This means companies can legally put NAC in their products without breaking the rules, as long as they follow other laws. People and businesses making or selling supplements with NAC should share their thoughts by January 19, 2027.
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-14967, Requirements for Additional Traceability Records for Certain Foods: Compliance Date Extension
The FDA is giving food businesses more time—30 extra months—to follow new rules about tracking certain foods. This means the deadline moves from January 2026 to July 2028, helping companies get ready without rushing. If you’re involved in food production or sales, this extension gives you a breather to avoid costly mistakes and meet the new tracking requirements smoothly.
Previous / Next Documents
Previous: 2025-08959, Notice of Annual Factors for Determining Administrative Fees for the Section 8 Housing Choice Voucher, Mainstream, and Moderate Rehabilitation Programs
Starting January 1, 2025, public housing agencies (PHAs) will use new monthly fee rates to cover the costs of running Section 8 Housing Choice Voucher, Mainstream, Emergency Housing Voucher, and Moderate Rehabilitation programs. These updated fees help PHAs plan their budgets and keep things running smoothly for families, seniors, and people with disabilities who need affordable housing. The changes ensure PHAs get fair support based on their local area costs.
Next: 2025-08961, Agency Information Collection Activity: Application for Dependency and Indemnity Compensation, Survivors Pension and Accrued Benefits by a Surviving Spouse or Child (Including Death Compensation if Available); Application for Dependency and Indemnity Compensation by a Surviving Spouse or Child-In-Service Death Only; and Application for DIC, Survivors Pension, and/or Accrued Benefits
The VA is updating its forms for survivors of veterans to apply for benefits like Dependency and Indemnity Compensation and Survivors Pension. They want your feedback on these changes by July 21, 2025, to make sure the forms are clear and easy to use. This helps survivors get the support they deserve without unnecessary hassle or delays.